Patents by Inventor Lele ZHAO

Lele ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250066748
    Abstract: The present invention provides a helicase BCH2X, comprising an amino acid sequence represented by any one of SEQ ID NOs: 1-3. The present invention also provides a complex structure comprising the helicase BCH2X and a binding moiety for binding polynucleotides. The present invention also provides a use of the helicase BCH2X or the complex structure comprising same in the control and characterization of polynucleotides and single-molecule nanopore sequencing.
    Type: Application
    Filed: December 31, 2021
    Publication date: February 27, 2025
    Inventors: Lele Wang, Tao Zeng, Zhenjun Liu, Junyi Chen, Ziyu Zhao, Denghui Li, Fei Guo, Zhouxiang Ji, Ou Wang, Yuxiang Li, Yuliang Dong, Wenwei Zhang, Xun Xu
  • Publication number: 20250066747
    Abstract: Provided is helicase BCH1X, which comprises an amino acid sequence represented by SEQ ID NO: 1 or 2. Further provided are a complex structure comprising helicase BCH1X and a binding moiety used for binding to a polynucleotide, and a use thereof in the control and characterization of a polynucleotide and in single molecule nanopore sequencing.
    Type: Application
    Filed: December 31, 2021
    Publication date: February 27, 2025
    Inventors: Xun Xu, Fei Guo, Qiaoxia Hu, Denghui Li, Junyi Chen, Lele Wang, Ziyu Zhao, Zhouxiang Ji, Tao Zeng, Ou Wang, Yuxiang Li, Yuliang Dong, Wenwei Zhang
  • Patent number: 12213067
    Abstract: This disclosure relates to techniques for multi-RAT and DSDA capable wireless devices to handle frame blanking in a wireless communication system. A wireless device may establish wireless links according to a first radio access technology and a second radio access technology. The wireless device may determine to perform transmit and receive blanking for one or more antennas of the wireless device for the first radio access technology to perform sounding reference signal transmissions for the second radio access technology based at least in part on a band combination for the wireless links. The wireless device may determine a modification to channel state feedback reporting for the first radio access technology based at least in part on the transmit and receive blanking. The wireless device may perform channel state feedback reporting using the determined modification.
    Type: Grant
    Filed: January 24, 2024
    Date of Patent: January 28, 2025
    Assignee: Apple Inc.
    Inventors: Junzhen Qin, Wen Zhao, Lijie Zhang, Lele Cui, Wenping Lou, Qiang Miao, Zhiwei Wang, Ying Zhang, Deepankar Bhattacharjee, Kexin Ma, Alex Yee Kit Ho
  • Patent number: 12024494
    Abstract: Provided are a compound III serving as an LSD1 inhibitor and a crystal form thereof, as well as use of the compound and the crystal form thereof in preparation of a medicament for treating an LSD1 related disease.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: July 2, 2024
    Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
    Inventors: Lele Zhao, Jianjun Sun, Lingyun Wu, Shuhui Chen
  • Publication number: 20240208945
    Abstract: Disclosed are 6-carbamate substituted heteroaryl ring derivatives and a preparation method therefor. The present application particularly relates to a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 24, 2022
    Publication date: June 27, 2024
    Inventors: Lingyun WU, Tianzi DAI, Lele ZHAO, Jianjun SUN, Yi QIAN, Jian LI, Shuhui CHEN
  • Publication number: 20240199571
    Abstract: The present invention relates to a thiophene compound and an application thereof. The present invention specifically relates to a compound represented by formula (II) and a pharmaceutically acceptable salt thereof, wherein L1 is —C(?O)— or —C(?O)—NH—; R1 is R1a or aa; ring A is bb or cc; R1a is C1-3 alkyl substituted with 1, 2 or 3 Ra; and R3 is independently H, halogen or C1-3 alkoxy. The compound represented by formula (II) and the pharmaceutically acceptable salt thereof can better inhibit the activity of LSD1, further shows significant inhibitory activity against NCI-H1417 cell proliferation, and has good pharmacokinetic properties (including good oral bioavailability, oral exposure, half-life, and clearance rate, etc.).
    Type: Application
    Filed: March 4, 2022
    Publication date: June 20, 2024
    Inventors: Lingyun WU, Zhen ZHAN, Lele ZHAO, Jianjun SUN, Yi QIAN, Shuhui CHEN
  • Publication number: 20240182457
    Abstract: Provided is a compound as represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 2, 2022
    Publication date: June 6, 2024
    Inventors: Lingyun WU, Xu YOU, Lele ZHAO, Shuhui CHEN
  • Publication number: 20240166610
    Abstract: Substituted pyridazine phenol derivatives and a preparation method therefor, specifically relating to a compound as shown in formula (VI) and a pharmaceutically acceptable salt thereof, which can be used as an NLRP3 inhibitor.
    Type: Application
    Filed: January 29, 2022
    Publication date: May 23, 2024
    Inventors: Lingyun WU, Lele ZHAO, Jianjun SUN, Chuang QIAO, Shuhui CHEN
  • Publication number: 20240150335
    Abstract: The present invention relates to a series of fused ring derivatives containing 1,4-oxazepane and a preparation method therefor, and in particular relates to a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 9, 2024
    Applicant: MEDSHINE DISCOVERY INC.
    Inventors: Lingyun WU, Lele ZHAO, Deheng CHEN, Xiaoxuan YAN, Shuhui CHEN
  • Patent number: 11852707
    Abstract: The present disclosure provides a system for SMS MRI. During each of a plurality of frames, the system may cause an MRI scanner to apply a plurality of PE steps to each of a plurality of slice locations of a subject to acquire echo signals. A phase modulation magnetic field gradient may be applied during each of at least some of the PE steps in the frame. For each frame, the system may reconstruct an aliasing image representative of the slice locations in the frame based on the corresponding echo signals. The system may also generate a plurality of reference slice images based on the aliasing images. The system may further reconstruct at least one slice image based on the aliasing images and the reference slice images. Each of the slice image may be representative of one of the slice locations in one of the frames.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: December 26, 2023
    Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
    Inventors: Yuan Zheng, Lele Zhao, Jian Xu, Weiguo Zhang
  • Publication number: 20230295076
    Abstract: Disclosed are an acetophenone oxime compound and a preparation method therefor, and specifically disclosed are a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 16, 2021
    Publication date: September 21, 2023
    Inventors: Lingyun Wu, Lele Zhao, Xinming Du, Xu You, Shuhui Chen
  • Patent number: 11760751
    Abstract: Disclosed are a series of benzo 2-azaspiro[4.4]nonane compounds, and specifically disclosed are a compound as represented by formula (P) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: September 19, 2023
    Assignee: HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun Wu, Peng Yang, Lele Zhao, Xu You, Jian Li, Shuhui Chen
  • Publication number: 20230126480
    Abstract: Disclosed are a series of benzo 2-azaspiro[4.4]nonane compounds, and specifically disclosed are a compound as represented by formula (P) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2021
    Publication date: April 27, 2023
    Applicants: HELIOEAST PHARMACEUTICAL CO., LTD., HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun WU, Peng YANG, Lele ZHAO, Xu YOU, Jian LI, Shuhui CHEN
  • Publication number: 20230124301
    Abstract: Disclosed in the present invention are a series of tricyclic compounds, and particularly disclosed are a compound shown in formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 2, 2021
    Publication date: April 20, 2023
    Applicants: HELIOEAST PHARMACEUTICAL CO., LTD., HELIOEAST SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Lingyun WU, Peng YANG, Lele ZHAO, Jian LI, Shuhui CHEN
  • Patent number: 11524941
    Abstract: Disclosed are a class of pyrazole compounds and applications thereof in the preparation of a medicament for treating related diseases. Specifically, related are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: December 13, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Lingyun Wu, Lele Zhao, Jianjun Sun, Zhen Zhan, Shuhui Chen
  • Publication number: 20220281895
    Abstract: Disclosed are pyrrolotriazine compounds which act as a mitogen-activated protein kinase interacting kinase (MNK) inhibitor, and the use thereof in the preparation of a mitogen-activated protein kinase interacting kinase inhibitor drug. Specifically disclosed are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 18, 2022
    Publication date: September 8, 2022
    Inventors: Lingyun WU, Xiawei WEI, Peng YANG, Lele ZHAO, Chen ZHANG, Ning JIANG, Wei ZHENG, Jian LI, Shuhui CHEN
  • Patent number: 11433053
    Abstract: A cyclopropylamine compound as a lysine-specific demethylase 1 (LSD1) inhibitor. Particularly, the present invention relates to a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The present invention also provides an application of the same in preparing a drug for treating an LSD1-related disease.
    Type: Grant
    Filed: January 24, 2018
    Date of Patent: September 6, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Lingyun Wu, Li Zhang, Lele Zhao, Jianjun Sun, Zhaoguo Chen, Jian Li, Shuhui Chen
  • Patent number: 11390625
    Abstract: Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: July 19, 2022
    Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Lingyun Wu, Xile Liu, Charles Z. Ding, Shuhui Chen, Lihong Hu, Lele Zhao, Wei Pan, Guoping Hu, Jian Li, Ning Zhao, Jun Zhao
  • Publication number: 20220119431
    Abstract: Provided are a salt of an EGFR inhibitor, a crystal form thereof and a preparation method therefor, and an application of the salt and the crystal form in the preparation of a treatment for non-small cell lung cancer. The salt has a structure as shown in formula (II).
    Type: Application
    Filed: January 17, 2020
    Publication date: April 21, 2022
    Inventors: Lingyun WU, Xile LIU, Charles Z. DING, Shuhui CHEN, Lihong HU, Lele ZHAO, Wei PAN, Guoping HU, Jian LI, Ning ZHAO, Jun ZHAO
  • Publication number: 20220064126
    Abstract: Disclosed are a class of pyrazole compounds and applications thereof in the preparation of a medicament for treating related diseases. Specifically, related are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 30, 2021
    Publication date: March 3, 2022
    Inventors: Lingyun WU, Lele ZHAO, Jianjun SUN, Zhen ZHAN, Shuhui CHEN